Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Mizuho Financial Group $1.75 billion senior notes offering
The senior callable fixed-to-fixed reset rate notes are due 2028 and 2033
Wayfair $690 million convertible senior notes offering
The 3.25% convertible notes are due 2027
Aon $500 million senior notes offering
The investment-grade notes are due 2032
Deutsche Bank $400 million notes offering
The fixed-rate senior debt funding notes are due 2027
MicroStrategy $500 million at-the-market offering
The stock is listed on the Nasdaq Global Market
Immunocore $250 million at-the-market offering
The ADSs are listed on the Nasdaq Global Market
Sitio Royalties $4.8 billion all-stock merger with Brigham Minerals
We are advising Sitio Royalties on the transaction
Biocytogen HK$549 million IPO
We advised Biocytogen on its IPO and HKEX listing
Red Star Macalline Group $249.7 million credit enhanced bonds offering
We advised the issuer on the credit enhanced bonds offering
Export Development Canada $3.25 billion global bond offering
The investment-grade bonds are due 2025